Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Mar 18, 2026 · Filed Mar 19, 2026
A board member of TransDigm sold $35K of TransDigm shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$35,449
Shares × reported transaction price
43 days after results of Feb 3, 2026, 27 days before results of Apr 14, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1,199.94 on Mar 18, 2026, at its 52-week low, after an 8% drop over the previous 30 trading days
52-week range $1,199.94 (Mar 18, 2026) to $1,620.83 (Jul 30, 2025), 0% of the way up, from 251 adjusted closes. 30 trading days earlier: $1,301.93 on Feb 3, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.2% | −2.2% | −0.9% |
| 30 days | +8.3% | +9.3% | −1.0% |
| 90 days | +12.8% | +15.1% | −2.3% |
| 180 days | −8.3% | +16.3% | −24.5% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
TransDigm's Co-Chief Operating Officer sold $297K of TransDigm shares. Nobody planned it ahead of time.
TransDigm's Co-Chief Operating Officer sold $153K of TransDigm shares. Nobody planned it ahead of time.